ArticleCancers2020

Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Takahiro Wakasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.